134 related articles for article (PubMed ID: 25812694)
21. Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours.
Rijlaarsdam MA; van Herk HA; Gillis AJ; Stoop H; Jenster G; Martens J; van Leenders GJ; Dinjens W; Hoogland AM; Timmermans M; Looijenga LH
Br J Cancer; 2011 Sep; 105(6):854-63. PubMed ID: 21847120
[TBL] [Abstract][Full Text] [Related]
22. Conclusive Evidence for OCT4 Transcription in Human Cancer Cell Lines: Possible Role of a Small OCT4-Positive Cancer Cell Population.
Miyamoto T; Mizuno N; Kosaka M; Fujitani Y; Ohno E; Ohtsuka A
Stem Cells; 2018 Sep; 36(9):1341-1354. PubMed ID: 29770522
[TBL] [Abstract][Full Text] [Related]
23. Novel spliced variants of OCT4, OCT4C and OCT4C1, with distinct expression patterns and functions in pluripotent and tumor cell lines.
Malakootian M; Mirzadeh Azad F; Naeli P; Pakzad M; Fouani Y; Taheri Bajgan E; Baharvand H; Mowla SJ
Eur J Cell Biol; 2017 Jun; 96(4):347-355. PubMed ID: 28476334
[TBL] [Abstract][Full Text] [Related]
24. Novel Variant of OCT4, Named OCT4B5, is Highly Expressed in Human Pluripotent Cells.
Mehravar M; Poursani EM
Stem Cell Rev Rep; 2021 Jun; 17(3):1068-1073. PubMed ID: 33241484
[TBL] [Abstract][Full Text] [Related]
25. OCT4B-190 protects against ischemic stroke by modulating GSK-3β/HDAC6.
Chen Y; Wu Z; Zhu X; Zhang M; Zang X; Li X; Xu Y
Exp Neurol; 2019 Jun; 316():52-62. PubMed ID: 30981804
[TBL] [Abstract][Full Text] [Related]
26. OCT4 expression in human uterine myometrial stem/progenitor cells.
Ono M; Kajitani T; Uchida H; Arase T; Oda H; Nishikawa-Uchida S; Masuda H; Nagashima T; Yoshimura Y; Maruyama T
Hum Reprod; 2010 Aug; 25(8):2059-67. PubMed ID: 20576635
[TBL] [Abstract][Full Text] [Related]
27. DNA methylation of the Oct4A enhancers in embryonal carcinoma cells after etoposide treatment is associated with alternative splicing and altered pluripotency in reversibly senescent cells.
Baryshev M; Inashkina I; Salmina K; Huna A; Jackson TR; Erenpreisa J
Cell Cycle; 2018; 17(3):362-366. PubMed ID: 29372665
[TBL] [Abstract][Full Text] [Related]
28. Novel variant of OCT4B4 is differentially expressed in human embryonic stem and embryonic carcinoma cells.
Poursani EM; Mehravar M; Soltani BM; Mowla SJ
Gene; 2017 Sep; 627():369-372. PubMed ID: 28633916
[TBL] [Abstract][Full Text] [Related]
29. Prognostication of OCT4 isoform expression in prostate cancer.
de Resende MF; Chinen LT; Vieira S; Jampietro J; da Fonseca FP; Vassallo J; Campos LC; Guimarães GC; Soares FA; Rocha RM
Tumour Biol; 2013 Oct; 34(5):2665-73. PubMed ID: 23636800
[TBL] [Abstract][Full Text] [Related]
30. Distinctive expression pattern of OCT4 variants in different types of breast cancer.
Soheili S; Asadi MH; Farsinejad A
Cancer Biomark; 2017; 18(1):69-76. PubMed ID: 27814277
[TBL] [Abstract][Full Text] [Related]
31. All the Tested Human Somatic Cells Express Both Oct4A and Its Pseudogenes but Express Oct4A at Much Lower Levels Compared with Its Pseudogenes and Human Embryonic Stem Cells.
Xu G; Yang L; Zhang W; Wei X
Stem Cells Dev; 2015 Jul; 24(13):1546-57. PubMed ID: 25687509
[TBL] [Abstract][Full Text] [Related]
32. OCT4B regulates p53 and p16 pathway genes to prevent apoptosis of breast cancer cells.
Meng L; Hu H; Zhi H; Liu Y; Shi F; Zhang L; Zhou Y; Lin A
Oncol Lett; 2018 Jul; 16(1):522-528. PubMed ID: 29930717
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of OCT4A and SPP1C transcript variant co-expression in early-stage lung adenocarcinoma.
Koshimune S; Kosaka M; Mizuno N; Yamamoto H; Miyamoto T; Ebisui K; Toyooka S; Ohtsuka A
BMC Cancer; 2020 Jun; 20(1):521. PubMed ID: 32503462
[TBL] [Abstract][Full Text] [Related]
34. Oct4A is expressed by a subpopulation of prostate neuroendocrine cells.
Sotomayor P; Godoy A; Smith GJ; Huss WJ
Prostate; 2009 Mar; 69(4):401-10. PubMed ID: 19058139
[TBL] [Abstract][Full Text] [Related]
35. A relative quantitative method to detect OCT4A gene expression by exon-junction primer and locked nucleic acid-modified probe.
Ren JJ; Meng XK
J Zhejiang Univ Sci B; 2011 Feb; 12(2):149-55. PubMed ID: 21265047
[TBL] [Abstract][Full Text] [Related]
36. Atypical expression and distribution of embryonic stem cell marker, OCT4, in human lung adenocarcinoma.
Karoubi G; Cortes-Dericks L; Gugger M; Galetta D; Spaggiari L; Schmid RA
J Surg Oncol; 2010 Nov; 102(6):689-98. PubMed ID: 20721963
[TBL] [Abstract][Full Text] [Related]
37. OCT4B expression in PBMNCs suggests the existence of an alternative OCT4 promoter.
Papamichos SI; Lambropoulos AF; Kotoula V
Genes Chromosomes Cancer; 2009 Dec; 48(12):1112-4. PubMed ID: 19760603
[No Abstract] [Full Text] [Related]
38. Differential Expression of OCT4 Pseudogenes in Pluripotent and Tumor Cell Lines.
Poursani EM; Mohammad Soltani B; Mowla SJ
Cell J; 2016; 18(1):28-36. PubMed ID: 27054116
[TBL] [Abstract][Full Text] [Related]
39. Analysis of Human Stem Cell Transcription Factors.
Sneha S; Nagare RP; Manasa P; Vasudevan S; Shabna A; Ganesan TS
Cell Reprogram; 2019 Aug; 21(4):171-180. PubMed ID: 31298562
[TBL] [Abstract][Full Text] [Related]
40. An Overview on the Complexity of OCT4: at the Level of DNA, RNA and Protein.
Mehravar M; Ghaemimanesh F; Poursani EM
Stem Cell Rev Rep; 2021 Aug; 17(4):1121-1136. PubMed ID: 33389631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
